Back to resultsRegisry of the Stroke Patients in Assiut University Hospital
Primary Purpose
All Patients With Ischemic Cerebrovascular Stroke Aged ≥18 Years of Both Sex
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
tissue plasminogen activator
thrombectomy
Sponsored by
About this trial
This is an interventional treatment trial for All Patients With Ischemic Cerebrovascular Stroke Aged ≥18 Years of Both Sex
Eligibility Criteria
Inclusion Criteria:
- All patients with stroke aged ≥18 years of both sex
- Written consent was taken for all patient either from the patient himself of closes relative after explaning to them the type of treatment benefits and possible risks
Exclusion Criteria:
- Stroke due to metabolic causes as hypoglycemia liver, Renal failure and other metabolic causes
- Stroke due to Brain tumors
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
tissue plasmnogen activator
thrombectoy
Arm Description
Outcomes
Primary Outcome Measures
Registry of the stroke Patients in Assist University Hospital
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03392792
Brief Title
Regisry of the Stroke Patients in Assiut University Hospital
Official Title
Regisry of the Stroke Patients in Assiut University Hospital
Study Type
Interventional
2. Study Status
Record Verification Date
January 2018
Overall Recruitment Status
Unknown status
Study Start Date
December 30, 2018 (Anticipated)
Primary Completion Date
December 30, 2018 (Anticipated)
Study Completion Date
December 30, 2018 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Assiut University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
• Aim of the work To register all type of acute stroke admitted in Assiut university Hospital and assessment of their risk factor, morbidity and Mortality
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
All Patients With Ischemic Cerebrovascular Stroke Aged ≥18 Years of Both Sex
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
1 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
tissue plasmnogen activator
Arm Type
Active Comparator
Arm Title
thrombectoy
Arm Type
Active Comparator
Intervention Type
Drug
Intervention Name(s)
tissue plasminogen activator
Other Intervention Name(s)
rtpa
Intervention Description
role of tissue plasminogen activator in patient with acute ischemic stroke having selective criteria for rTPA
Intervention Type
Procedure
Intervention Name(s)
thrombectomy
Intervention Description
role of thrombectomy in patient with acute ischemic stroke
Primary Outcome Measure Information:
Title
Registry of the stroke Patients in Assist University Hospital
Time Frame
one year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
All patients with stroke aged ≥18 years of both sex
Written consent was taken for all patient either from the patient himself of closes relative after explaning to them the type of treatment benefits and possible risks
Exclusion Criteria:
Stroke due to metabolic causes as hypoglycemia liver, Renal failure and other metabolic causes
Stroke due to Brain tumors
12. IPD Sharing Statement
Learn more about this trial
Regisry of the Stroke Patients in Assiut University Hospital
We'll reach out to this number within 24 hrs